Biotech Updates

Get Exclusive Access to the ISAAA Global Biotech/GM Adoption Report

January 21, 2026

For nearly three decades, the ISAAA Global Status of Commercialized GM/Biotech Crops has been recognized as the world's most authoritative source of adoption data. Since its inception in 1996, this report, authored by ISAAA Founder Dr. Clive James and Executive Director Dr. Rhodora Romero-Aldemita, has served as a significant source of insights for agri-biotech players.

In February 2026, ISAAA will release the highly anticipated 2024 adoption report. To ensure our community has exclusive access to these critical insights, we are introducing enhanced Biotech Updates subscription plans. These plans are designed to provide subscribers with the full scope of global biotech trends alongside our regular research and regulatory updates.

The Elite subscription plan (US$100) offers the most value, pairing the full report with specialized regional analysis to be released every quarter. As a special incentive, individuals who join the Elite tier by January 31, 2026, will also receive the Brief 57 slide deck, a visual companion containing the key findings. A Premium subscription plan (US$50) is also available for those seeking the full report only.

Secure an upgraded Biotech Updates subscription today. For corporate subscription inquiries, send an e-mail to knowledgecenter@isaaa.org .


You might also like: